Carsten Niemann

Carsten Niemann

Clinical Associate Professor

Member of:

  • Internal Medicine: Haematology


Publication year:
All
1 - 21 out of 21Page size: 100
  1. 2022
  2. Published

    Anti-PD-L1/PD-L2 therapeutic vaccination in untreated chronic lymphocytic leukemia patients with unmutated IgHV

    Klausen, U., Grauslund, J. H., Jørgensen, N. G. D., Ahmad, S. M., Jonassen, M., Weis-Banke, S. E., Martinenaite, E., Pedersen, L. B., Lisle, T. L., Gang, Anne Ortved, Enggaard, L., Hansen, M., Holmström, M. O., Met, Özcan, Svane, Inge Marie, Niemann, Carsten, Pedersen, Lars Møller & Andersen, Mads Hald, 2022, In: Frontiers in Oncology. 12, 1023015.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Artificial intelligence models in chronic lymphocytic leukemia–recommendations toward state-of-the-art

    Agius, R., Parviz, M. & Niemann, Carsten, 2022, In: Leukemia and Lymphoma. 63, 2, p. 265-278 14 p.

    Research output: Contribution to journal › Review › Research › peer-review

  4. Published

    CLL-106 First Prospective Data on Minimal Residual Disease Outcomes After Fixed-Duration Ibrutinib Plus Venetoclax Versus Chlorambucil Plus Obinutuzumab for First-Line Treatment of CLL in Older Adult or Unfit Patients: The GLOW Study

    Munir, T., Moreno, C., Owen, C., Follows, G., Benjamini, O., Janssens, A., Levin, M. D., Osterborg, A., Robak, T., Simkovic, M., Stevens, D., Voloshin, S., Vorobyev, V., Yagci, M., Ysebaert, L., Qi, Q., Steele, A., Schuier, N., Baeten, K., Caces, D. B. & 2 others, Niemann, Carsten & Kater, A., 2022, In: Clinical Lymphoma, Myeloma and Leukemia. 22, p. S264-S265

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

  5. Published

    CLL-IPI applied in Binet A CLL: a nationwide cohort study

    Rotbain, E. C., da Cunha-Bang, C., Brieghel, C. & Niemann, Carsten, 2022, In: Blood advances. 6, 21, p. 5698-5701 4 p.

    Research output: Contribution to journal › Letter › Research › peer-review

  6. Published

    COVID-19 Infection in Patients with Chronic Lymphocytic Leukemia Receiving Acalabrutinib in the Phase 3B ASSURE Study

    Niemann, Carsten, Awan, F. T., Fogliatto, L., Nikitin, E., Samoilova, O., Habib, A., Foroutanpour, K., Kuptsova-Clarkson, N. & Opat, S., 2022, In: HemaSphere. 6, 10, p. E780

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Chest x-ray imaging score is associated with severity of COVID-19 pneumonia: the MBrixia score

    Jensen, C. M., Costa, J. C., Nørgaard, J. C., Zucco, Adrian G., Neesgaard, B., Niemann, Carsten, Ostrowski, Sisse Rye, Reekie, J., Holten, B., Kalhauge, A., Matthay, M. A., Lundgren, Jens, Helleberg, Marie & Moestrup, K. S., 2022, In: Scientific Reports. 12, 21019.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Chronic lymphocytic leukaemia clones are detectable decades before diagnosis

    Vojdeman, F. J., Helby, J., Pedersen, L. B., Brieghel, C., Andersen, M. A., Nordestgaard, Børge, Bojesen, Stig Egil & Niemann, Carsten, 2022, In: British Journal of Haematology. 196, 3, p. 784-787

    Research output: Contribution to journal › Letter › Research › peer-review

  9. Published

    Clinicobiological characteristics and treatment efficacy of novel agents in chronic lymphocytic leukemia with IGLV3-21(R110)

    Hengeveld, P. J., Ertem, Y. E., Dubois, J. M. N., Mellink, C. H. M., van der Kevie-kersemaekers, A., Evers, L. M., Heezen, K., Kolijn, P. M., Mook, O. R. F., Motazacker, M. M., Nasserinejad, K., Kersting, S., Westerweel, P. E., Niemann, Carsten, Kater, A. P., Langerak, A. W. & Levin, M., 2022, In: Leukemia. 36, 7, p. 1935-1938 4 p.

    Research output: Contribution to journal › Letter › Research › peer-review

  10. Published

    Clonal hematopoiesis is associated with hematological toxicity during lenalidomide-based therapy for MCL

    Husby, Simon, Bæch-Laursen, C., Eskelund, C. W., Favero, Francesco, Jespersen, Jakob Schmidt, Hutchings, M., Pedersen, L. B., Niemann, Carsten, Weischenfeldt, Joachim Lütken, Räty, R., Larsen, T. S., Kolstad, A., Jerkeman, M. & Grønbæk, Kirsten, 2022, In: Leukemia. 36, p. 2912-2916

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Early stimulated immune responses predict clinical disease severity in hospitalized COVID-19 patients

    Svanberg, R., MacPherson, C., Zucco, A., Agius, R., Faitova, T., Andersen, M. A., da Cunha-Bang, C., Gjærde, L. K., Møller, M. E. E., Brooks, P. T., Lindegaard, B., Sejdic, A., Harboe, Z. B., Gang, A. O., Hersby, D. S., Brieghel, C., Nielsen, S. D., Podlekareva, D., Hald, A., Bay, J. T. & 6 others, Marquart, Hanne Vibeke Hansen, Lundgren, Jens, Lebech, Anne-Mette, Helleberg, Marie, Niemann, Carsten & Ostrowski, Sisse Rye, 2022, In: Communications Medicine. 2, 15 p., 114.

    Research output: Contribution to journal › Journal article › Research › peer-review

  12. Published

    Identifying patients with chronic lymphocytic leukemia without need of treatment: End of endless watch and wait?

    Brieghel, C., Galle, V., Agius, R., da Cunha-Bang, C., Andersen, M. A., Vlummens, P., Mattsson, M., Rosenquist, R., Smedby, K. E., Herling, C. D., Bahlo, J., Hallek, M., Lundgren, Jens, Offner, F. & Niemann, Carsten, 2022, In: European Journal of Haematology. 108, 5, p. 369-378 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  13. Published

    Minimal residual disease-guided stop and start of venetoclax plus ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia (HOVON141/VISION): primary analysis of an open-label, randomised, phase 2 trial

    Kater, A. P., Levin, M. D., Dubois, J., Kersting, S., Enggaard, L., Veldhuis, G. J., Mous, R., Mellink, C. H. M., van der Kevie-Kersemaekers, A. M. F., Dobber, J. A., Poulsen, C. B., Frederiksen, H., Janssens, A., Schjødt, I., Dompeling, E. C., Ranti, J., Brieghel, C., Mattsson, M., Bellido, M., Tran, H. T. T. & 2 others, Nasserinejad, K. & Niemann, Carsten, 2022, In: The Lancet Oncology. 23, 6, p. 818-828 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  14. Published

    Obinutuzumab (GA-101), ibrutinib, and venetoclax (GIVe) frontline treatment for high-risk chronic lymphocytic leukemia

    Huber, H., Edenhofer, S., von Tresckow, J., Robrecht, S., Zhang, C., Tausch, E., Schneider, C., Bloehdorn, J., Fürstenau, M., Dreger, P., Ritgen, M., Illmer, T., Illert, A. L., Dürig, J., Böttcher, S., Niemann, C. U., Kneba, M., Fink, A-M., Fischer, K., Döhner, H. & 3 others, Hallek, M., Eichhorst, B. & Stilgenbauer, S., 2022, In: Blood. 139, 9, p. 1318-1329 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  15. Published

    Patients with CLL have a lower risk of death from COVID-19 in the Omicron era

    Niemann, Carsten, da Cunha-Bang, C., Helleberg, M., Ostrowski, Sisse Rye & Brieghel, C., 2022, In: Blood. 140, 5, p. 445-450 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  16. Published

    Personalized survival probabilities for SARS-CoV-2 positive patients by explainable machine learning

    Zucco, Adrian G., Agius, R., Svanberg, R., Moestrup, K. S., Marandi, R. Z., MacPherson, C. R., Lundgren, Jens, Ostrowski, Sisse Rye & Niemann, Carsten, 2022, In: Scientific Reports. 12, 13879.

    Research output: Contribution to journal › Journal article › Research › peer-review

  17. Published

    Pre-diagnostic trajectories of lymphocytosis predict time to treatment and death in patients with chronic lymphocytic leukemia

    Andersen, M. A., Grand, Mia Klinten, Brieghel, C., Siersma, Volkert Dirk, Andersen, Christen Bertel L & Niemann, Carsten, 2022, In: Communications Medicine. 2, 8 p., 50.

    Research output: Contribution to journal › Journal article › Research › peer-review

  18. Published

    Prediction of clinical outcome in CLL based on recurrent gene mutations, CLL-IPI variables, and (para)clinical data

    Parviz, M., Brieghel, C., Agius, R. & Niemann, Carsten, 2022, In: Blood advances. 6, 12, p. 3716-3728 13 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  19. Published

    Serological response following vaccination with BNT162b2 mRNA in patients with chronic lymphocytic leukemia

    da Cunha-Bang, C., Kirkby, N. S., Friis-Hansen, Lennart Jan & Niemann, Carsten, 2022, In: Leukemia and Lymphoma. 63, 2, p. 503-505

    Research output: Contribution to journal › Letter › Research › peer-review

  20. Published

    Serum proteome modulations upon treatment provides biological insight on response to treatment in relapsed mantle cell lymphoma

    Lokhande, L., Kuci Emruli, V., Eskelund, C. W., Kolstad, A., Hutchings, M., Räty, R., Niemann, Carsten, Grønbæk, Kirsten, Jerkeman, M. & Ek, S., 2022, In: Cancer Reports. 5, 8 p., e1524.

    Research output: Contribution to journal › Journal article › Research › peer-review

  21. Published

    The CLL comorbidity index in a population-based cohort: a tool for clinical care and research

    Rotbain, E. C., Gordon, M. J., Vainer, N., Frederiksen, H., Hjalgrim, Henrik, Danilov, A. V. & Niemann, Carsten, 2022, In: Blood advances. 6, 8, p. 2701-2706 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  22. Published

    The gut microbiome in patients with chronic lymphocytic leukemia

    Faitová, T., Svanberg, R., Da Cunha-Bang, C., Ilett, E. E., Jørgensen, M., Noguera-Julian, M., Paredes, R., MacPherson, C. R. & Niemann, Carsten, 2022, In: Haematologica. 107, 9, p. 2238-2243 6 p.

    Research output: Contribution to journal › Letter › Research › peer-review

ID: 185059285